MedTrace Logo

Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy

NCT06120829 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 490

Last updated 2023-11-07

No results posted yet for this study

Summary

Cryobiopsy of peripheral lymph nodes with suspected malignant potential with comparison to standard core needle biopsy.

Conditions

  • Cryobiopsy of Peripheral Lymph Nodes

Interventions

PROCEDURE

Cryobiopsy

Use of 1.1mm ERBE 2 disposable cryoprobe for tissue sampling

DEVICE

Cryobiopsy

Use of 1.1mm ERBE 2 disposable cryoprobe for tissue sampling

PROCEDURE

Core Needle Biopsy

Core Needle Biopsy

Sponsors & Collaborators

  • San Antonio Uniformed Services Health Education Consortium

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2025-06-30
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06120829 on ClinicalTrials.gov